Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract CT157: Phase 1 dose-escalation study of linclatamig, a LY6G6D×CD3 T cell-engaging bispecific antibody, in patients with colorectal cancer

Cancer Res (2025) 85 (8_Supplement_2): CT157.

https://doi.org/10.1158/1538-7445.AM2025-CT157

Published: 25 April 2025

View articletitled, Abstract CT157: Phase 1 dose-escalation study of linclatamig, a LY6G6D×CD3 T cell-engaging bispecific antibody, in patients with colorectal cancer

Journal Articles

Abstract B091: Mechanisms underlying the omental support of ovarian cancer peritoneal metastasis

Rachel Mintz, Alexandre Gallerand, Jichang Han, Sarah Ning, Wei Zou, Mary Wohltmann, Bernd Zinselmeyer, Gwendalyn Randolph

Cancer Res (2024) 84 (5_Supplement_2): B091.

https://doi.org/10.1158/1538-7445.OVARIAN23-B091

Published: 04 March 2024

View articletitled, Abstract B091: Mechanisms underlying the omental support of ovarian cancer peritoneal metastasis

Journal Articles

Abstract 5358: Digital SP263 PD-L1 tumor cell scoring in non-small cell lung cancer achieves comparable outcome prediction to manual pathology scoring

Hen Prizant, John Shamshoian, John Abel, Andrew Beck, Laura Chambre, Stephanie Hennek, Hartmut Koeppen, Daniel Ruderman, Meghna Das Thakur, Michael Montalto, Benjamin Trotter, Ilan Wapinski, Wei Zou, Minu K. Srivastava, Jennifer Giltnane

Cancer Res (2023) 83 (7_Supplement): 5358.

https://doi.org/10.1158/1538-7445.AM2023-5358

Published: 04 April 2023

View articletitled, Abstract 5358: Digital SP263 PD-L1 tumor cell scoring in non-small cell lung cancer achieves comparable outcome prediction to manual pathology scoring

Journal Articles

Abstract 5176: Tumor dynamic model-based decision support for phase Ib immunotherapy combination studies

René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Y. Jin

Cancer Res (2022) 82 (12_Supplement): 5176.

https://doi.org/10.1158/1538-7445.AM2022-5176

Published: 15 June 2022

View articletitled, Abstract 5176: Tumor dynamic model-based decision support for phase Ib immunotherapy combination studies

Journal Articles

Abstract 5707: On-treatment changes in CRP as a surrogate for overall survival for atezolizumab benefit in 2^nd line NSCLC

Namrata Patil, Wei Zou, Simonetta Mocci, Vinita Gupta, Luciana Molinero, Alan Sandler, Marcus Ballinger, Susan Flynn, Marcin Kowanetz, Priti Hegde

Cancer Res (2018) 78 (13_Supplement): 5707.

https://doi.org/10.1158/1538-7445.AM2018-5707

Published: 01 July 2018

View articletitled, Abstract 5707: On-treatment changes in CRP as a surrogate for overall survival for atezolizumab benefit in 2nd line NSCLC

Journal Articles

Abstract CT076: IMpower150: Efficacy of atezolizumab (atezo) plus bevacizumab (bev) and chemotherapy (chemo) in 1L metastatic nonsquamous NSCLC (mNSCLC) across key subgroups

Marcin Kowanetz, Mark A. Socinski, Wei Zou, Mark McCleland, Nancy Yang, Ariel Lopez Chavez, Alexander Spira, Julien Mazières, Fadi Braiteh, David Shames, Alan Sandler, Martin Reck

Cancer Res (2018) 78 (13_Supplement): CT076.

https://doi.org/10.1158/1538-7445.AM2018-CT076

Published: 01 July 2018

View articletitled, Abstract CT076: IMpower150: Efficacy of atezolizumab (atezo) plus bevacizumab (bev) and chemotherapy (chemo) in 1L metastatic nonsquamous NSCLC (mNSCLC) across key subgroups

Journal Articles

Antagonizing Integrin β3 Increases Immunosuppression in Cancer

Cancer Res (2016) 76 (12): 3484–3495.

https://doi.org/10.1158/0008-5472.CAN-15-2663

Published: 14 June 2016

View articletitled, Antagonizing Integrin β3 Increases Immunosuppression in Cancer

Includes: Supplementary data

Journal Articles

Abstract 1768: Comprehensive mass spectrometry based metabolomic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer

Shiro Urayama, Wei Zou, Vladimir Tolstikov

Cancer Res (2010) 70 (8_Supplement): 1768.

https://doi.org/10.1158/1538-7445.AM10-1768

Published: 15 April 2010

View articletitled, Abstract 1768: Comprehensive mass spectrometry based metabolomic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer

Journal Articles

CD47 Regulates Bone Mass and Tumor Metastasis to Bone

Özge Uluçkan, Stephanie N. Becker, Hongju Deng, Wei Zou, Julie L. Prior, David Piwnica-Worms, William A. Frazier, Katherine N. Weilbaecher

Cancer Res (2009) 69 (7): 3196–3204.

https://doi.org/10.1158/0008-5472.CAN-08-3358

Published: 01 April 2009

View articletitled, CD47 Regulates Bone Mass and Tumor Metastasis to Bone

Includes: Supplementary data

Journal Articles

Coupling of Endoplasmic Reticulum Stress to CDDO-Me–Induced Up-regulation of Death Receptor 5 via a CHOP–Dependent Mechanism Involving JNK Activation

Wei Zou, Ping Yue, Fadlo R. Khuri, Shi-Yong Sun

Cancer Res (2008) 68 (18): 7484–7492.

https://doi.org/10.1158/0008-5472.CAN-08-1318

Published: 14 September 2008

View articletitled, Coupling of Endoplasmic Reticulum Stress to CDDO-Me–Induced Up-regulation of Death Receptor 5 via a CHOP–Dependent Mechanism Involving JNK Activation

Journal Articles

CAAT/Enhancer Binding Protein Homologous Protein–Dependent Death Receptor 5 Induction Is a Major Component of SHetA2-Induced Apoptosis in Lung Cancer Cells

Yi-Dan Lin, Shuzhen Chen, Ping Yue, Wei Zou, Doris M. Benbrook, Shengquan Liu, Thanh C. Le, K. Darrell Berlin, Fadlo R. Khuri, Shi-Yong Sun

Cancer Res (2008) 68 (13): 5335–5344.

https://doi.org/10.1158/0008-5472.CAN-07-6209

Published: 01 July 2008

View articletitled, CAAT/Enhancer Binding Protein Homologous Protein–Dependent Death Receptor 5 Induction Is a Major Component of SHetA2-Induced Apoptosis in Lung Cancer Cells

Includes: Supplementary data

Journal Articles

The Farnesyltransferase Inhibitor R115777 Up-regulates the Expression of Death Receptor 5 and Enhances TRAIL-Induced Apoptosis in Human Lung Cancer Cells

Yuanzheng Qiu, Xiangguo Liu, Wei Zou, Ping Yue, Sagar Lonial, Fadlo R. Khuri, Shi-Yong Sun

Cancer Res (2007) 67 (10): 4973–4980.

https://doi.org/10.1158/0008-5472.CAN-06-4044

Published: 17 May 2007

View articletitled, The Farnesyltransferase Inhibitor R115777 Up-regulates the Expression of Death Receptor 5 and Enhances TRAIL-Induced Apoptosis in Human Lung Cancer Cells

Journal Articles

c-Jun N-terminal kinase (JNK)-independent c-FLIP downregulation contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells.

Wei Zou, Shuzhen Chen, Xiangguo Liu, Ping Yue, Michael B. Sporn, Fadlo R. Khur, Shi-Yong Sun

Cancer Res (2007) 67 (9_Supplement): 5139.

Published: 01 May 2007

View articletitled, c-Jun N-terminal kinase (JNK)-independent c-FLIP downregulation contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells.

Journal Articles

PPARγ ligands induce death receptor 5 (DR5) expression and redistribution in lipid rafts and enhance TRAIL-induced apoptosis in human lung cancer cells

Wei Zou, Xiangguo Liu, Ping Yue, Fadlo R Khuri, Shi-Yong Sun

Cancer Res (2006) 66 (8_Supplement): 180.

Published: 15 April 2006

View articletitled, PPARγ ligands induce death receptor 5 (DR5) expression and redistribution in lipid rafts and enhance TRAIL-induced apoptosis in human lung cancer cells

Journal Articles

c-Jun NH₂-Terminal Kinase-Mediated Up-regulation of Death Receptor 5 Contributes to Induction of Apoptosis by the Novel Synthetic Triterpenoid Methyl-2-Cyano-3,12-Dioxooleana-1, 9-Dien-28-Oate in Human Lung Cancer Cells

Wei Zou, Xiangguo Liu, Ping Yue, Zhongmei Zhou, Michael B. Sporn, Reuben Lotan, Fadlo R. Khuri, Shi-Yong Sun

Cancer Res (2004) 64 (20): 7570–7578.

https://doi.org/10.1158/0008-5472.CAN-04-1238

Published: 15 October 2004

View articletitled, c-Jun NH2-Terminal Kinase-Mediated Up-regulation of Death Receptor 5 Contributes to Induction of Apoptosis by the Novel Synthetic Triterpenoid Methyl-2-Cyano-3,12-Dioxooleana-1, 9-Dien-28-Oate in Human Lung Cancer Cells

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract CT157: Phase 1 dose-escalation study of linclatamig, a LY6G6D×CD3 T cell-engaging bispecific antibody, in patients with colorectal cancer

Abstract B091: Mechanisms underlying the omental support of ovarian cancer peritoneal metastasis

Abstract 5358: Digital SP263 PD-L1 tumor cell scoring in non-small cell lung cancer achieves comparable outcome prediction to manual pathology scoring

Abstract 5176: Tumor dynamic model-based decision support for phase Ib immunotherapy combination studies

Abstract 5707: On-treatment changes in CRP as a surrogate for overall survival for atezolizumab benefit in 2^nd line NSCLC

Abstract CT076: IMpower150: Efficacy of atezolizumab (atezo) plus bevacizumab (bev) and chemotherapy (chemo) in 1L metastatic nonsquamous NSCLC (mNSCLC) across key subgroups

Antagonizing Integrin β3 Increases Immunosuppression in Cancer

Abstract 1768: Comprehensive mass spectrometry based metabolomic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer

CD47 Regulates Bone Mass and Tumor Metastasis to Bone

Coupling of Endoplasmic Reticulum Stress to CDDO-Me–Induced Up-regulation of Death Receptor 5 via a CHOP–Dependent Mechanism Involving JNK Activation

CAAT/Enhancer Binding Protein Homologous Protein–Dependent Death Receptor 5 Induction Is a Major Component of SHetA2-Induced Apoptosis in Lung Cancer Cells

The Farnesyltransferase Inhibitor R115777 Up-regulates the Expression of Death Receptor 5 and Enhances TRAIL-Induced Apoptosis in Human Lung Cancer Cells

c-Jun N-terminal kinase (JNK)-independent c-FLIP downregulation contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells.

PPARγ ligands induce death receptor 5 (DR5) expression and redistribution in lipid rafts and enhance TRAIL-induced apoptosis in human lung cancer cells

c-Jun NH₂-Terminal Kinase-Mediated Up-regulation of Death Receptor 5 Contributes to Induction of Apoptosis by the Novel Synthetic Triterpenoid Methyl-2-Cyano-3,12-Dioxooleana-1, 9-Dien-28-Oate in Human Lung Cancer Cells

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only